China Enacts Modernized Clinical Trial Guidelines to Enhance Patient Safety

ASCO 2026: Accelerating Equitable Clinical Trial Access Worldwide

Nature Op-ed: China’s Evolving Position in Global Pharmaceuticals

China Normalizes 30-Day Review for High-Value and MRCT Pipelines

Launch of Rural American Task Force

ASCO 2025: Cure4Cancer Champions Co-Create Tailored Cancer Care and Drive Lung Cancer Breakthroughs

Panel Discussion on Healthy China 2030

Cure4Cancer & Asia Society Publish Second Global Health Equity Report

Asia Society Report shows patient access to oncology clinical trials remains below 5% globally

Forbes China Healthcare Summit on ‘Advancing Global Health Equity to Cure Cancer’